State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 25 01 2019
accepted: 17 06 2019
pubmed: 30 6 2019
medline: 2 4 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

Anger is involved in the emotional experience of pain. Individuals with migraine are more likely to hold their anger-in than controls. However, only one study evaluated anger in cluster headache (CH). The objective is to compare anger between migraine and CH patients. One hundred thirty-five migraine and 108 CH patients completed the State Trait Anger Expression Inventory (STAXI-2), composed of 7 subscales. State Anger measures the intensity of the individual's angry feelings at the time of testing. Trait Anger evaluates general predisposition to become angry. Anger Expression Out and Anger Expression In measure the extent to which anger could be overtly expressed or suppressed. Anger Control Out and Anger Control In evaluate how individual try to control the outward or inward expression of anger. Anger Expression Index is a general index. CH patients have higher median scores than migraine patients in State Anger (46 vs 44, p = 0.012). CH patients have lower scores in Anger Control Out (44 vs 50, p = 0.016). In subgroup analysis, CH patients during the cluster period have higher scores than chronic migraine patients in State Anger (47 vs 44, p = 0.035), while CH patients in headache-free period did not differ from migraine patients. Migraine and CH patients differ in state anger, indicating that CH patients experienced higher intensity of anger during the time of testing. These data add new information about emotional regulation in headache patients and could support the hypothesis of different emotional and behavioral responses to pain in migraine and CH patients.

Sections du résumé

BACKGROUND BACKGROUND
Anger is involved in the emotional experience of pain. Individuals with migraine are more likely to hold their anger-in than controls. However, only one study evaluated anger in cluster headache (CH). The objective is to compare anger between migraine and CH patients.
METHODS METHODS
One hundred thirty-five migraine and 108 CH patients completed the State Trait Anger Expression Inventory (STAXI-2), composed of 7 subscales. State Anger measures the intensity of the individual's angry feelings at the time of testing. Trait Anger evaluates general predisposition to become angry. Anger Expression Out and Anger Expression In measure the extent to which anger could be overtly expressed or suppressed. Anger Control Out and Anger Control In evaluate how individual try to control the outward or inward expression of anger. Anger Expression Index is a general index.
RESULTS RESULTS
CH patients have higher median scores than migraine patients in State Anger (46 vs 44, p = 0.012). CH patients have lower scores in Anger Control Out (44 vs 50, p = 0.016). In subgroup analysis, CH patients during the cluster period have higher scores than chronic migraine patients in State Anger (47 vs 44, p = 0.035), while CH patients in headache-free period did not differ from migraine patients.
CONCLUSIONS CONCLUSIONS
Migraine and CH patients differ in state anger, indicating that CH patients experienced higher intensity of anger during the time of testing. These data add new information about emotional regulation in headache patients and could support the hypothesis of different emotional and behavioral responses to pain in migraine and CH patients.

Identifiants

pubmed: 31254182
doi: 10.1007/s10072-019-03987-0
pii: 10.1007/s10072-019-03987-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2365-2370

Références

Headache. 2012 Apr;52(4):600-11
pubmed: 22077836
Headache. 2003 Jun;43(6):651-63
pubmed: 12786926
Cephalalgia. 2012 May;32(7):528-36
pubmed: 22665916
Headache. 2001 Jan;41(1):21-30
pubmed: 11168600
Curr Pain Headache Rep. 2013 Feb;17(2):313
pubmed: 23296640
Neurol Sci. 2019 May;40(Suppl 1):3-7
pubmed: 30906966
J Behav Med. 2006 Dec;29(6):593-606
pubmed: 16807797
Neurol Sci. 2018 Jun;39(Suppl 1):3-9
pubmed: 29904829
Psychother Psychosom. 2007;76(2):122-8
pubmed: 17230053
Neurol Sci. 2017 Feb;38(2):295-301
pubmed: 27838832
Neurol Sci. 2012 May;33 Suppl 1:S107-9
pubmed: 22644183
J Headache Pain. 2005 Oct;6(5):392-9
pubmed: 16362712
Ann Behav Med. 2013 Oct;46(2):181-92
pubmed: 23620190
Lancet. 1998 Jul 25;352(9124):275-8
pubmed: 9690407
Headache. 2010 Feb;50(2):273-89
pubmed: 20039962
Clin J Pain. 1994 Mar;10(1):3-9
pubmed: 8193443
Health Psychol. 2015 May;34(5):547-55
pubmed: 25110843
Curr Pain Headache Rep. 2005 Apr;9(2):101-5
pubmed: 15745619
Int Rev Psychiatry. 2017 Oct;29(5):504-515
pubmed: 28681617
J Psychosom Res. 2000 Jul;49(1):69-75
pubmed: 11053606
Neurol Sci. 2017 May;38(Suppl 1):157-161
pubmed: 28527057
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
Headache. 2007 Mar;47(3):413-26
pubmed: 17371358
J Clin Psychol. 2016 Mar;72(3):263-78
pubmed: 26766132
Lancet Neurol. 2006 Oct;5(10):873-7
pubmed: 16987734

Auteurs

Marialuisa Rausa (M)

Department of Biomedical and Neuromotor Sciences DIBINEM, University of Bologna, Via Altura 3, 40100, Bologna, Italy. m.rausa@gmail.com.
Centro Gruber, Diagnosis and Treatment Center of Eating and Weight Disorders, Diagnosis and Treatment of Anxiety and Psychosomatic Disorders, Via Santo Stefano, 10, 40100, Bologna, Italy. m.rausa@gmail.com.

Sabina Cevoli (S)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura, 3, 40100, Bologna, Italy.

Giulia Giannini (G)

Department of Biomedical and Neuromotor Sciences DIBINEM, University of Bologna, Via Altura 3, 40100, Bologna, Italy.

Valentina Favoni (V)

Department of Biomedical and Neuromotor Sciences DIBINEM, University of Bologna, Via Altura 3, 40100, Bologna, Italy.

Sara Anastasia Contin (SA)

Centro Gruber, Diagnosis and Treatment Center of Eating and Weight Disorders, Diagnosis and Treatment of Anxiety and Psychosomatic Disorders, Via Santo Stefano, 10, 40100, Bologna, Italy.

Corrado Zenesini (C)

Neuroepidemiology Research Unit, Servizio di Epidemiologia e Biostatistica, IRCCS-Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40100, Bologna, Italy.

Donatella Ballardini (D)

Centro Gruber, Diagnosis and Treatment Center of Eating and Weight Disorders, Diagnosis and Treatment of Anxiety and Psychosomatic Disorders, Via Santo Stefano, 10, 40100, Bologna, Italy.

Pietro Cortelli (P)

Department of Biomedical and Neuromotor Sciences DIBINEM, University of Bologna, Via Altura 3, 40100, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura, 3, 40100, Bologna, Italy.

Giulia Pierangeli (G)

Department of Biomedical and Neuromotor Sciences DIBINEM, University of Bologna, Via Altura 3, 40100, Bologna, Italy.
Centro Gruber, Diagnosis and Treatment Center of Eating and Weight Disorders, Diagnosis and Treatment of Anxiety and Psychosomatic Disorders, Via Santo Stefano, 10, 40100, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura, 3, 40100, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH